{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:21:05Z","timestamp":1778520065295,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.humpath.2025.105783","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:03:02Z","timestamp":1746547382000},"page":"105783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["TFE3\/TFEB altered renal cell carcinomas in end-stage renal disease setting: A single institution clinicopathological study of 4 cases"],"prefix":"10.1016","volume":"158","author":[{"given":"Andrea","family":"Mladenovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara R.","family":"Harik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin K.","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Genega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-6579","authenticated-orcid":false,"given":"Jatin S.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105783_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.juro.2006.04.007","article-title":"Renal cell carcinoma associated with end stage renal disease","volume":"176","author":"Petrolla","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.105783_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib3","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1046\/j.1523-1755.2002.00374.x","article-title":"Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis","volume":"61","author":"Denton","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.humpath.2025.105783_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/00313020310001619901","article-title":"Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas","volume":"35","author":"Argani","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2025.105783_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-4608(97)82578-2","article-title":"Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13)","volume":"91","author":"Dijkhuizen","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2025.105783_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/geno.2000.6194","article-title":"Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints","volume":"66","author":"van Asseldonk","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.humpath.2025.105783_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.23007","article-title":"Translocation carcinomas of the kidney","volume":"61","author":"Argani","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2025.105783_bib11","first-page":"125","article-title":"MiT family translocation renal cell carcinomas: a 15th anniversary update","volume":"35","author":"Gandhi","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.humpath.2025.105783_bib12","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","article-title":"Translocation carcinomas of the kidney after chemotherapy in childhood","volume":"24","author":"Argani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105783_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.07.014","article-title":"Secondary renal neoplasia following chemotherapy or radiation in pediatric patients","volume":"103","author":"Gupta","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12912","article-title":"TFE3-positive renal cell carcinoma occurring in three children with dysfunctional kidneys on immunosuppression","volume":"21","author":"Schaefer","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.humpath.2025.105783_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13000-016-0551-x","article-title":"An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report","volume":"11","author":"Yu","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1464-410X.2009.08817.x","article-title":"Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis","volume":"105","author":"Nouh","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2025.105783_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12253-016-0179-x","article-title":"Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients","volume":"23","author":"Kuthi","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.humpath.2025.105783_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/his.13866","article-title":"RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review","volume":"75","author":"Kato","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105783_bib19","series-title":"AJCC cancer staging manual","year":"2017"},{"key":"10.1016\/j.humpath.2025.105783_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.13167","article-title":"Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105783_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/10668969221143455","article-title":"MED15::TFE3 renal cell carcinomas: report of two new cases and review of the literature confirming nearly universal multilocular cystic morphology","volume":"31","author":"Argani","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2023.03.008","article-title":"Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature","volume":"136","author":"Doytcheva","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.pas.0000152131.58492.97","article-title":"Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study","volume":"29","author":"Sule","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","article-title":"Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic spectrum","volume":"44","author":"Xia","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105783_bib25","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0931430100","article-title":"Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation","volume":"100","author":"Davis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2025.105783_bib26","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/hmg\/ddg178","article-title":"Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution","volume":"12","author":"Kuiper","year":"2003","journal-title":"Hum Mol Genet"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T17:14:50Z","timestamp":1748020490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772500070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":26,"alternative-id":["S004681772500070X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105783","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TFE3\/TFEB altered renal cell carcinomas in end-stage renal disease setting: A single institution clinicopathological study of 4 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105783"}}